MedTrace Logo

Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD

NCT00307268 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195

Last updated 2013-01-23

No results posted yet for this study

Summary

To evaluate clinical effectiveness of medication treatment for ADHD. It is hypothesized that the effectiveness is lower than efficacy outcomes measured in clinical trials

Conditions

  • Attention-Deficit/Hyperactivity Disorder (ADHD)

Sponsors & Collaborators

  • Eli Lilly and Company

    collaborator INDUSTRY

  • Janssen-Ortho LLC

    collaborator INDUSTRY

  • Purdue University

    collaborator OTHER

  • Shire

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Margaret Weiss, MD, PhD · The University of British Columbia

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-01-31
Completion
2012-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00307268 on ClinicalTrials.gov